The use of double promoter toxin vector H19-DTA-(IGF2)-P4-DTA exhibited superior inhibition towards pancreatic cancer, ovarian cancer, glioblastoma and HCC (Amit and Hochberg, 2012). The gene discussed is H19; the disease is hepatocellular carcinoma.